Subcutaneous Infusions

08/01/2006 - "Also described are ways in which it may help to reduce the chance of accidental error when setting up and monitoring the delivery of 24-hour subcutaneous infusions for pain and symptom control."
05/01/2006 - "Subcutaneous infusion-site pain was the most frequently reported side effect, with one subject withdrawing from the study as a result. "
12/01/2012 - "Syringe drivers are routinely used in palliative care for the subcutaneous infusion of drugs for pain and symptom control. "
06/01/2012 - "The use of subcutaneous infusion tumescent anesthesia in photodynamic therapy pain control."
10/01/2010 - "Is continuous subcutaneous infusion a good route for pain medication?"

01/01/2015 - "A drug-disease model based on the turnover concept fit tumor growth curves inhibited by PF06463922 and PF06471402 with estimated unbound tumor stasis concentrations of 51 and 27 nM, respectively, for oral administration, and 116 and 70 nM, respectively, for subcutaneous infusion. "
03/01/2013 - "In advanced cancer patients, subcutaneous infusion is easy, advantageous, and accompanied by less discomfort. "
12/01/2003 - "We present the technique and the preliminary results of percutaneous implantation of intraarterial catheters connected to a subcutaneous infusion reservoir for prolonged regional chemotherapy of hepatic tumors. "
01/01/2002 - "Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care."
05/01/2000 - "We present the technique and the preliminary results of percutaneous implantation of intraarterial catheters connected to a subcutaneous infusion reservoir for prolonged regional chemotherapy of hepatic and extrahepatic tumors. "

03/01/1982 - "The use of portable devices for the subcutaneous infusion of insulin may facilitate the attainment of improved glycemic control in selected patients with insulin-dependent diabetes mellitus. "
05/01/2012 - "Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus."
02/20/1991 - "We conclude that subcutaneous infusion of octreotide for 12 weeks reduces increased glomerular filtration rate and kidney size in patients with insulin-dependent diabetes mellitus despite the fact that glycemic control remains unchanged."
01/01/2003 - "The efficacy of insulin aspart was similar to that of insulin lispro when administered to patients with type 1 diabetes mellitus via continuous subcutaneous infusion in a randomized, nonblind trial. "
01/01/2002 - "The efficacy of insulin aspart was similar to that of insulin lispro when administered to patients with type 1 diabetes mellitus via continuous subcutaneous infusion in a randomised, nonblind trial. "

12/01/2011 - "Data on the total dose received in the last 24 h of life PRN and the last dose prescribed for administration via continuous subcutaneous infusion (CSCI) for agitation and restlessness were submitted. "
02/01/1993 - "It has proved effective in controlling terminal agitation, confusion, restlessness, dystonia and fitting in adults and can be given by subcutaneous infusion in combination with other drugs. "
08/01/1990 - "Midazolam by subcutaneous infusion is a well-tolerated, safe and effective treatment for terminal restlessness and agitation, and deserves more extensive evaluation."
08/01/1990 - "This article describes the use of a subcutaneous infusion of midazolam to control restlessness and agitation in 23 patients during the final stages of advanced cancer. "
07/01/1992 - "Sublingual lorazepam and continuous subcutaneous infusion of midazolam can be effective in controlling terminal restlessness."

12/01/2013 - "Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease."
12/01/2013 - "Subcutaneous infusion of apomorphine is a useful treatment for motor and nonmotor complications in Parkinson's disease patients and improves the patient's quality of life. "
01/01/2011 - "Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect."
07/01/2014 - "The role of subcutaneous infusion of apomorphine in Parkinson's disease."
03/01/2014 - "[Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients]."